Overview

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to test the efficacy of the combination treatment AllQbG10 in patients with perennial allergic rhinoconjunctivitis due to house dust mite allergy in a double-blind placebo-controlled setting
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Cytos Biotechnology AG
Criteria
Inclusion Criteria:

- Mild to moderate perennial allergic rhinoconjunctivits due to hypersensitization
towards house dust mite allergens

Exclusion Criteria:

- Clinically relevant other allergies (perennial or seasonal) that could potentially
interfere with the patient's study treatment schedule or assessments

- Use of any concomitant medication that could affect the patient's study treatment
response or assessment results